[HTML][HTML] Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK …
A Hassanzade, A Mandegary, E Sharif… - Iranian journal of …, 2018 - ncbi.nlm.nih.gov
Objective (s): Combination chemotherapy is a rational strategy to increase patient response
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways …
A Hassanzade, A Mandegary, E Sharif… - Iranian Journal of …, 2018 - europepmc.org
Objectives Combination chemotherapy is a rational strategy to increase patient response
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
[PDF][PDF] Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK …
A Hassanzade, A Mandegary, E Sharif, R Rasooli… - cancer - pdfs.semanticscholar.org
Materials and Methods: The cytotoxicity of celecoxib or indomethacin, alone and in
combination with DDW and DEW was determined. The COX-2, MAPK pathway proteins, the …
combination with DDW and DEW was determined. The COX-2, MAPK pathway proteins, the …
Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways
A Hassanzadeh, A Mandegary, E Sharif… - Iranian Journal of …, 2018 - search.proquest.com
Objective (s): Combination chemotherapy is a rational strategy to increase patient response
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
[PDF][PDF] Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK …
A Hassanzade, A Mandegary, E Sharif, R Rasooli… - cancer - sid.ir
Materials and Methods: The cytotoxicity of celecoxib or indomethacin, alone and in
combination with DDW and DEW was determined. The COX-2, MAPK pathway proteins, the …
combination with DDW and DEW was determined. The COX-2, MAPK pathway proteins, the …
[PDF][PDF] Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK …
A Hassanzade, A Mandegary, E Sharif, R Rasooli… - cancer - researchgate.net
Materials and Methods: The cytotoxicity of celecoxib or indomethacin, alone and in
combination with DDW and DEW was determined. The COX-2, MAPK pathway proteins, the …
combination with DDW and DEW was determined. The COX-2, MAPK pathway proteins, the …
Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways
A Hassanzadeh, A Mandegary, E Sharif… - Iranian Journal of …, 2018 - ijbms.mums.ac.ir
Objective (s): Combination chemotherapy is a rational strategy to increase patient response
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways
A Hassanzadeh, A Mandegary, E Sharif… - Iranian Journal of …, 2018 - journals.mums.ac.ir
Objective (s): Combination chemotherapy is a rational strategy to increase patient response
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways
A Hassanzade, A Mandegary… - Iranian journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Objectives Combination chemotherapy is a rational strategy to increase patient response
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways …
A Hassanzade, A Mandegary, E Sharif… - Iranian Journal of …, 2018 - search.ebscohost.com
Objective (s): Combination chemotherapy is a rational strategy to increase patient response
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …
and tolerability and to decrease adverse effects and drug resistance. Recently, the use of …